Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single Dose Sildenafil in Heart Failure
NCT00781508Phase 4Completed
- Sponsor
- MetroHealth Medical Center
- Start
- Dec 2006
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ASP-001 in heart failure (HF) (2 arms), sponsored by MetroHealth Medical Center. Primary endpoint: Reduction of the Left Ventricular Filling Pressure at 1 hour. Started Dec 2006; status: completed.
02
Drugs
ASP-001
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00781508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00781508.